Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q2 2025 Earnings Call Transcript
Operator: Good morning, and welcome to the Axsome Therapeutics Second Quarter 2025 Financial Results Conference Call. [Operator Instructions] Please note this call is being recorded.